{{Rsnum
|rsid=13900
|Gene=CCL2
|Chromosome=17
|position=34256892
|Orientation=plus
|GMAF=0.4059
|Gene_s=CCL2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 44.2 | 50.4 | 5.3
| HCB | 14.1 | 46.7 | 39.3
| JPT | 9.7 | 51.3 | 38.9
| YRI | 66.0 | 29.3 | 4.8
| ASW | 56.1 | 36.8 | 7.0
| CHB | 14.1 | 46.7 | 39.3
| CHD | 22.9 | 44.0 | 33.0
| GIH | 54.5 | 36.6 | 8.9
| LWK | 54.1 | 41.3 | 4.6
| MEX | 29.3 | 46.6 | 24.1
| MKK | 62.8 | 32.7 | 4.5
| TSI | 50.0 | 45.1 | 4.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=23166687
|Title=The rs1024611 Regulatory Region Polymorphism Is Associated with CCL2 Allelic Expression Imbalance
|OA=1
}}

{{PMID Auto
|PMID=24023637
|Title=Gender-Specific Effects of Genetic Variants within Th1 and Th17 Cell-Mediated Immune Response Genes on the Risk of Developing Rheumatoid Arthritis
|OA=1
}}

{{PMID Auto
|PMID=16672419
|Title=Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation.
|OA=1
}}

{{PMID Auto
|PMID=17065190
|Title=Monocyte chemotactic protein-1 single nucleotide polymorphisms do not confer susceptibility for the development of adult onset polymyositis/dermatomyositis in UK Caucasians.
}}

{{PMID Auto
|PMID=18698231
|Title=Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues.
|OA=1
}}

{{PMID Auto
|PMID=20339010
|Title=CCL2 and CCR2 polymorphisms are associated with markers of exercise-induced skeletal muscle damage.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}